FIELD: organic chemistry and medicine.
SUBSTANCE: invention relates to new imidazole derivatives of general formula I 
useful as adenosine A3-receptor modulators, as well as to method for cancer treatment and detection of tumor cells using claimed derivatives.
EFFECT: compounds for treatment and diagnosis of improved activity.
13 cl, 4 dwg, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRIAZOLE[4,5-d]PYRIMIDINE DERIVATIVES AND USES THEREOF AS PUTINOCEPTOR ANTAGONISTS | 2002 |
|
RU2317084C2 |
| DERIVATIVES OF SUBSTITUTED TRIAZOLDIAMINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS PREPARING | 2001 |
|
RU2274639C2 |
| HETEROBICYCLO-SUBSTITUTED-[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES | 2013 |
|
RU2671628C2 |
| TRIAZOLO[1,5-a]QUINOLINES AS LIGANDS OF ADENOSINE A3 RECEPTOR | 2008 |
|
RU2489432C2 |
| HETEROARYL[4,3-c]PYRIMIDINE-5-AMINE DERIVATIVE, ITS PREPARATION METHOD AND ITS MEDICAL APPLICATIONS | 2018 |
|
RU2764655C2 |
| DNA-DEPENDENT PROTEIN KINASE INHIBITOR | 2020 |
|
RU2835434C2 |
| DERIVATIVES OF 8-METHOXY-[1,2,4]TRIAZOLO[1,5-a]PYRIDINE AND PHARMACEUTICAL PREPARATION BASED ON THEREOF | 2002 |
|
RU2297416C2 |
| PYRAZOLOPYRIMIDINE COMPOUNDS AS ADENOSINE RECEPTOR ANTAGONISTS | 2019 |
|
RU2806758C2 |
| METHODS AND MEDICAL APPLICATIONS | 2018 |
|
RU2788174C2 |
| SUBSTITUTED [1,2,4]TRIAZOLO[4,3-a]PYRIDINES, DEMONSTRATING PROPERTIES OF ANTAGONISTS OF ADENOSINE A2A RECEPTORS, AND THEIR APPLICATION | 2013 |
|
RU2534804C1 |
